Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.


  1. Advanced Patent Search
Publication numberUSD411445 S
Publication typeGrant
Application numberUS 29/081,517
Publication dateJun 22, 1999
Filing dateDec 30, 1997
Priority dateJun 30, 1997
Publication number081517, 29081517, US D411445 S, US D411445S, US-S-D411445, USD411445 S, USD411445S
InventorsGregor J.M. Anderson
Original AssigneeGlaxo Group Limited
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Holder for blister packs
US D411445 S
Abstract  available in
Previous page
Next page
  1. The ornamental design for a "holder for blister packs", as shown and described.

FIG. 1 is an exploded perspective view of a holder for blister packs shown without the parts of the holder for the blister packs for clarity of illustration, illustrated in a partially open position in accordance with my design.

FIG. 2 is a bottom perspective view illustrating the parts of the holder for the blister packs in an open position, shown without the cap for clarity of illustration;

FIG. 3 is a top plan view of FIG. 2, with the parts of the holder for the blister packs separated from in another;

FIG. 4 is a bottom plan view thereof;

FIG. 5 is a cross-sectional view taken generally about the line 5--5 in IFG. 3; and,

FIG. 6 is a perspective view of the holder for blister packs, fully assembled and in a closed position.

Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US6981592 *Oct 11, 2002Jan 3, 2006Medical Technologies Systems, Inc.Product packaging material for individual temporary storage of pharmaceutical products
US7150355Sep 2, 2004Dec 19, 2006Pharmadesign Inc.Case with pill receiving sleeves for storing and dispensing pills
US7942267Dec 18, 2006May 17, 2011Pharmadesign Inc.Case with pill receiving sleeves for storing and dispensing pills
US8415332Aug 17, 2007Apr 9, 2013TEVA Woman's Health, Inc.A female is administered an estrogen and a progestin for a period of greater than 30 or 31 consecutive days to provide contraceptive and non-contraceptive benefits; reduce bleeding problems; multiphase adminstering with variation in dosage; ethinyl estradiol
US8450299Jun 8, 2012May 28, 2013Teva Womans's Health, Inc.Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
U.S. ClassificationD03/203.3